Carboplatin and Paclitaxel Plus ASA404 as First Line Chemotherapy for Extensive-Stage Small-Cell Lung Cancer (ES-SCLC): A Phase II Trial.
Phase of Trial: Phase II
Latest Information Update: 23 Aug 2013
At a glance
- Drugs Carboplatin; Paclitaxel; Vadimezan
- Indications Small cell lung cancer
- Focus Therapeutic Use
- Acronyms ES-SCLC
- 31 Jul 2012 Actual end date (Jul 2012) added as reported by ClinicalTrials.gov.
- 01 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Jun 2012 Planned end date changed from 1 Mar 2012 to 1 Aug 2012 as reported by ClinicalTrials.gov.